SCHEMBL14202808

SCHEMBL14202808

Cc1ccc(Cl)cc1NC(=O)CS

nearest known ligand 0.76

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.69
GAA P10253 2/20 0.69
ALDH1A1 P00352 3/20 0.68
LMNA P02545 3/20 0.68
TSHR P16473 2/20 0.64
HTT P42858 2/20 0.62
MAPT P10636 2/20 0.62
SMN1; SMN2 Q16637 1/20 0.61
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59
THRB P10828 1/20 0.56
TDP1 Q9NUW8 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9620133 0.85 GAA (0.77) POLBGAAALDH1A1LMNATSHR
SCHEMBL4005240 0.85 GAA (0.71) POLBGAAALDH1A1LMNATSHR
SCHEMBL9181550 0.83 POLB (0.69) POLBGAAALDH1A1LMNATSHR
SCHEMBL7934469 0.83 POLB (0.77) POLBGAAALDH1A1LMNAMAPT
SCHEMBL21561682 0.83 HDAC3 (0.62) POLBALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL1068813 0.80 GAA (0.65) POLBGAAALDH1A1LMNATSHR
SCHEMBL20812868 0.80 LMNA (0.57) POLBGAAALDH1A1LMNATSHR
SCHEMBL7936652 0.80 MEN1 (0.53) POLBGAAALDH1A1LMNAMAPT
SCHEMBL1509787 0.80 ALDH1A1 (0.51) POLBGAAALDH1A1HTTMAPT
SCHEMBL7931375 0.80 KMT2A (0.80) POLBALDH1A1LMNAMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090891-A1 ION CHANNEL MODULATORS WYETH (US) 2008-04-17 US disclosed
US-20080090891-A1 ION CHANNEL MODULATORS WYETH (US) 2008-04-17 US disclosed
US-20070281937-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070281937-A1 Ion Channel Modulators CACNA1B, CACNA1C, TRPV1 POLB 4663/4885GAA 1560/4885ALDH1A1 3706/4885
US-20080090891-A1 ION CHANNEL MODULATORS CACNA1B, CACNA1C, TRPV1 POLB 4663/4885GAA 1560/4885ALDH1A1 3706/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.